Study of MLN8237 in Combination With Irinotecan and Temozolomide
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Doxycycline, Temozolomide and Ipilimumab in Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Metformin in Children With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents
- Status
- TERMINATED
- Phase
- PHASE2
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
- Status
- TERMINATED
- Phase
- PHASE2
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Low Dose Radiation Therapy for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
- Status
- TERMINATED
- Phase
- PHASE1
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
- Status
- COMPLETED
- Phase
- PHASE2